STOCK TITAN

JACK IN THE BOX INC SEC Filings

JACK NASDAQ

Welcome to our dedicated page for JACK IN THE BOX SEC filings (Ticker: JACK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on JACK IN THE BOX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into JACK IN THE BOX's regulatory disclosures and financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.64%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
other
Rhea-AI Summary

Jack in the Box Inc. (NASDAQ: JACK) has adopted a Stockholder Protection Rights Agreement—commonly known as a poison pill—effective July 1, 2025. Shareholders of record on July 14, 2025 will receive a dividend of one Right for each common share. Each Right becomes exercisable only after a Separation Time, triggered when any person or group acquires or commences a tender offer for 12.5 % or more of the company’s outstanding shares. Upon activation, a Right allows the holder to buy, for $90, one-one-thousandth of a share of Participating Preferred Stock—economically equivalent to diluting the acquirer by giving other investors the right to purchase stock at an effective 50 % discount.

Key terms

  • Exercise price: $90 per Right.
  • Expiration: July 1, 2026, extendable to July 1, 2028 if ratified by stockholders.
  • Redemption: Board may redeem all Rights at $0.001 per Right any time before a Flip-in Date.
  • Flip-in threshold: 12.5 % beneficial ownership.
  • Flip-over protection: Ensures equivalent value if a merger or major asset sale occurs after an acquirer controls ≥50 % of shares.

The plan is administered by Computershare Trust Company, N.A. as Rights Agent. Management argues that the Rights protect shareholders by encouraging anyone seeking control to negotiate directly with the Board. However, governance-focused investors often view poison pills as potential entrenchment tools that can block takeover premiums. The adoption follows no announced bid, suggesting a pre-emptive defense amid elevated M&A activity in the fast-food sector. No financial results were disclosed in this 8-K.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.86%
Tags
current report

FAQ

How many JACK IN THE BOX (JACK) SEC filings are available on StockTitan?

StockTitan tracks 84 SEC filings for JACK IN THE BOX (JACK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for JACK IN THE BOX (JACK)?

The most recent SEC filing for JACK IN THE BOX (JACK) was filed on August 6, 2025.